Number of the records: 1  

Gemcitabine alone versus combination of gemcitabine and cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a retrospective analysis of multicenter study

  1. SYS0079355
    LBL
      
    00000naa^^22^^^^^^^^450
    005
      
    20150928094808.8
    100
      
    $a 20120809a2012 m y0sloy0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Gemcitabine alone versus combination of gemcitabine and cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a retrospective analysis of multicenter study $f A. Inal ... [et al.]
    215
      
    $c ilustr., grafy, tab.
    320
      
    $a Bibliogr. odkazy
    320
      
    $a Res. angl.
    463
    -1
    $1 001 sllk_un_cat*0078216 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 59, no. 3 (2012), s. 297-301 $1 210 $a Bratislava $c AEPress $d 2012 $1 215 $a s. 237-354
    541
    1-
    $a Gemcitabín samostatne verzus kombinácia gemcitabínu a cisplatiny na liečbu pacientov s lokálne pokročilým a /alebo metastatickým karcinómom pankreasu: multicentrická štúdia s retrospektívnou analýzou $z slo
    606
    1-
    $3 sllk_un_auth*d010190 $a nádory pankreasu $x farmakoterapia $2 mesh
    606
    2-
    $3 sllk_un_auth*d000230 $a adenokarcinóm $2 mesh
    606
    2-
    $3 sllk_un_auth*d009362 $a metastázy nádorové $2 mesh
    606
    2-
    $3 sllk_un_auth*d054697 $a cytostatiká $x použitie terapeutické $x toxicita $2 mesh
    606
    2-
    $3 sllk_un_auth*d002945 $a cisplatina $2 mesh
    606
    2-
    $3 sllk_un_auth*d004358 $a farmakoterapia $x účinky nežiaduce $2 mesh
    606
    1-
    $3 sllk_un_auth*d004359 $a farmakoterapia kombinovaná $2 mesh
    606
    1-
    $3 sllk_un_auth*d016896 $a výsledok liečby $2 mesh
    606
    2-
    $3 sllk_un_auth*d018572 $a prežívanie bez choroby $2 mesh
    606
    2-
    $3 sllk_un_auth*d015337 $a štúdie multicentrické ako téma $2 mesh
    610
    2-
    $a gemcitabín
    610
    2-
    $a chemoterapia prvolíniová
    701
    -1
    $3 sllk_un_auth*0026367 $a Inal $b A. $p Department of Medical Oncology, Dicle University, Diyarbakir, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026371 $a Kos $b F. T. $p Department of Medical Oncology, Ankara Numune Education and Research Hospital, Ankara, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026374 $a Algin $b E. $p Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026376 $a Yildiz $b R. $p Dr. Lüfti Kirdal Kartal Education and Research Hospital, Istanbul, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0001878 $a Dikilitas $b M. $p Erciyes University Medical School, Departments of Medical Oncology, Kayseri, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026378 $a Unek $b I. T. $p Department of Medical Oncology, Dokuz Eylül University, Izmir, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026379 $a Colak $b D. $p Yildirim Beyazit Education and Research Hospital, Ankara, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026380 $a Elkiran $b E. T. $p Department of Medical Oncology, Firat University, Elazig, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026381 $a Helvaci $b K. $p Dr. Abdurrahman Yurtaslan Education and Research Hospital, Istanbul, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026382 $a Geredeli $b C. $p Meram Medical Faculty, Secuk University, Konya, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026383 $a Dane $b F. $p Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026384 $a Balakan $b O. $p Department of Medical Oncology, Giazantep University, Giazantep, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026368 $a Kaplan $b M. A. $p Department of Medical Oncology, Dicle University, Diyarbakir, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026385 $a Durnali $b A. G. $p Dr. Abdurrahman Yurtaslan Education and Research Hospital, Istanbul, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026386 $a Harputoglu $b H. $p Department of Medical Oncology, Inonu University, Malatya, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026387 $a Goksel $b G. $p Department of Medical Oncology, Celal Bayar University, Manisa, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026372 $a Ozdemir $b N. $p Department of Medical Oncology, Ankara Numune Education and Research Hospital, Ankara, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0001869 $a Buyukberber $b S. $p Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026377 $a Gumus $b M. $p Dr. Lüfti Kirdal Kartal Education and Research Hospital, Istanbul, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026369 $a Kucukoner $b M. $p Department of Medical Oncology, Dicle University, Diyarbakir, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0024306 $a Ozkan $b S. $p Department of Emergency, Faculty of Medicine, Erciyes University, Kayseri, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026373 $a Uncu $b D. $p Department of Medical Oncology, Ankara Numune Education and Research Hospital, Ankara, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0001885 $a Benekli $b M. $p Gazi University Medical School, Departments of Medical Oncology, Ankara, Turkey $4 070
    701
    -1
    $3 sllk_un_auth*0026370 $a Isikdogan $b A. $p Department of Medical Oncology, Dicle University, Diyarbakir, Turkey $4 070
    801
    -0
    $a SK $b BA006 $c 20120809 $g AACR2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.